Cast Your Ballot! 2017 ISPE Board of Directors Election
In late July 2017, ISPE members will have the opportunity to exercise their right to vote for their 2017 Board of Directors. Current ISPE members will receive electronic ballots by email from Intelliscan, Inc., ISPE’s independent election partner. (Editor’s note: Make sure to add “@intelliscaninc.net” to your safe senders list.) Members for whom an updated email address does not exist will receive a postcard with voting instructions. The election closes at 11:59 PM EDT on 13 September 2017. The Board Nominating Committee and Board Officer Nominating Committee vet candidates nominated by ISPE members.
Aligning Action With Strategic Direction
ISPE’s board is composed of fifteen members (five officers and 10 directors) plus the society’s CEO and President, who serves as a nonvoting ex officio member. Directors are elected to two-year terms and can serve up to two consecutive terms; officers make a five-year commitment to rotate through the executive roles of Secretary through Past Chair in one-year terms.
“As ISPE’s main decision-making body, the Board establishes the society’s vision and mission, articulates strategic priorities, and ensures that business operations are consistent with society policies, best practices, and relevant laws,” said John Bournas, ISPE CEO and President. A seat on the Board entails considerable responsibility, and candidates who seek election know that the demanding nomination process cannot be taken lightly. Members are encouraged to reacquaint themselves with the ISPE 2016- 2019 Strategic Plan Summary and to consider ISPE’s business objectives when casting a ballot for their representatives.
Before traveling to the 2019 ISPE Annual Meeting & Expo in Las Vegas, the ISPE Japan Affiliate held its annual phar-maceutical plant tour over five days (21–25 October), visiting two plants in Los Angeles, one in Boston, and one in In-dianapolis.
The 2019 ISPE Max Seales Yonker Member of the Year Award was presented to Charlie Wakeham, a data integrity and compliance specialist based in Sydney, Australia, who has played an instrumental role in the development of GAMP®.